Company page

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. (Ticker: NRIX) is a public company based in the United States, focused on developing innovative therapies for cancer and other diseases. With a market capitalization of approximately $1.84 billion, Nurix is engaged in advancing its proprietary drug discovery platform. The company aims to harness the power of targeted protein modulation to create effective treatment options.